Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Physicians who Perform Breast Implant Surgery

Articles with lock require a subscription to GLG News | Request a free trial
August 7, 2008
why not do cosmetic surgery/procedures? why not get paid?
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
without question, medicine has changed.  dermatologists and plastic surgeons can make considerably more money, and be paid in cash by catering to "cosmetic" patients.  No wonder fewer and fewer surgeons/dermatologists are interested in treating skin cancers, scars, lacerations etc.  Why...
Robert FrankJuly 31, 2008
Dermatologists? I worry more about the Family practitioners, Ob-Gyns, and Internists...
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: Robert Frank, Owner, Aria Cosmetic and Reconstructive Surgery
As insurance reimbursements decline, everyone suddenly thinks they're a cosmetic surgeon.
Alan ZaccariaJuly 8, 2008
And yet, another filler? Is this the Holy Grail?
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: Alan Zaccaria, Plastic Surgeon, Alan Zaccaria, MD, FACS
Over the past few years, noninvasive cosmetic procedures have skyrocketed.  Soft tissue injectable fillers are among those procedures that are rapidly growing.  Up until now, hyaluronic acid (HA) fillers have been the mainstay.  With the emergence of Envolence, we have a new twist on...
July 3, 2008
why are we going backwards
Analysis of: FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Author: GLG Expert Contributor
makes no sense to introduce a product that does not last as long as others on the market unless you are going t sell it to the patient at a substantial prce savings. Even in that scenario, needle fatigue wil eventually make the patient seek a different filler.
Alan ZaccariaMay 27, 2008
Stay Away From Liquid Silicone Injections.
Analysis of: Renal Failure Linked to Cosmetic Soft-Tissue Filler Injections | www.medscape.com
Author: Alan Zaccaria, Plastic Surgeon, Alan Zaccaria, MD, FACS
Only FDA approved fillers administered by experienced, licensed physicians should be injected into patients.  Also, the small volumes that are used today should not pose systemic problems that were seen in this article.
Robert FrankMarch 14, 2008
Phase 2 trials show significantly improved scars
Analysis of: Juvista Phase II Trial Results in Scar Revision and Breast Augmentation Surgery | www.renovo.com
Author: Robert Frank, Owner, Aria Cosmetic and Reconstructive Surgery
Juvista appears to be effective in improving scar quality according to recently released Phase II results. Renovo reported no clinical improvement in breast augmentation scars treated with a single injection of the drug.
Robert FrankFebruary 7, 2008
Botox competitors can't come soon enough
Analysis of: Efficacy of Botulinum Toxin Does Not Sag Over Time | www.medscape.com
Author: Robert Frank, Owner, Aria Cosmetic and Reconstructive Surgery
Botox from Allergan has enjoyed an exclusive monopoly for the past nine years. Alternative drugs do not appear to be available as soon as was hoped.
Alan ZaccariaDecember 14, 2007
Topical "Botox"--Sounds Like a Winner
Analysis of: Medicis and Revance Announce Strategic Collaboration | www.pipelinereview.com
Author: Alan Zaccaria, Plastic Surgeon, Alan Zaccaria, MD, FACS
It is not unexpected that Medicis is expanding into the "Botox" business since its rival company, Allergan, has a monopoly on the market.  Allergan also has Juviderm, which competes directly with Restylane, the hit product by Medicis.  This will place Medicis back into the competitive market...
September 25, 2007
Physician House Calls- A potential major trend in the health care industry
Analysis of: The New York Times | www.nytimes.com
Author: GLG Expert Contributor
Physician house calls may represent an emerging major trend in fee-for-service health care delivery. The urgent care center emerged in the 80's and 90's as a novel way for patients to avoid emergency rooms. Of course, this is based on the patient's willingness to pay a fee that is not covered by insurance....
September 24, 2007
Inurance reimbursement for MWL body contouring
Analysis of: Bariatric surgery - possible treatment for type 2 diabetes mellitus | www.news-medical.net
Author: GLG Expert Contributor
I have seen a trend of decreased reimbursements in my practice with post MWL body contouring.  These patients are plagued with complications due to their malabsorption.  Wound healing and seroma formations are issues that are encountered close to 100% of all MWL patients who undergo elective...

Page : 1 2 3 4 5 Next1 to 10 of 44

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-09-06T17:45:17.377